Modulation of the Phosphoinositide 3-Kinase Pathway Alters Innate Resistance to Polymicrobial Sepsis

Journal of Immunology

Volumn 172, Issue 1, 2004, Pages 449-456

  Williams, David L ^a   Li, Chuanfu ^a   Ha, Tuanzhu ^a   Ozment Skelton, Tammy ^a   Kalbfleisch, John H ^a   Preiszner, Johanna ^a   Brooks, Lynne ^a   Breuel, Kevin ^a   Schweitzer, John B ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; HOMEOSTASIS; IMMUNE RESPONSE; INFLAMMATION; MALE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SPLEEN CELL; SURVIVAL TIME;

EID: 0346103719     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.1.449     Document Type: Article

References (41)

1. Oberholzer, A., C. Oberholzer, and L. L. Moldawer. 2001. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16:83.
2. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303.
3. Fruman, D. A., and L. C. Cantley. 2002. Phosphoinositide 3-kinase in immunological systems. Semin. Immunol. 14:7.
4. Cantley, L. C. 2002. The phosphoinositide 3-kinase pathway. Science 296:1655.
5. Guha, M., and N. Mackman. 2002. The PI3K-Akt pathway limits LPS activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277:32124.
6. Fukao, T., and S. Koyasu. 2003. PI3K and negative regulation of TLR signaling. Trends Immunol. 24:358.
7. Williams, D. L., T. Ha, C. Li, J. H. Kalbfleisch, and D. A. Ferguson, Jr. 1999. Early activation of hepatic NFκB and NF-IL6 in polymicrobial sepsis correlates with bacteremia, cytokine expression and mortality. Ann. Surg. 230:95.
8. Browder, W., T. Ha, C. Li, J. H. Kalbfleisch, D. A. Ferguson, Jr., and D. L. Williams. 1999. Early activation of pulmonary nuclear factor κB and nuclear factor interleukin-6 in polymicrobial sepsis. J. Trauma: Injury Infect. Crit. Care 46:590.
9. Williams, D. L., T. Ha, C. Li, J. H. Kalbfleisch, J. J. Laffan, and D. A. Ferguson. 1999. Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1→3)-β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery 126:54.
10. Williams, D. L., T. Ha, C. Li, J. Laffan, J. Kalbfleisch, and W. Browder. 2000. Inhibition of LPS induced NFκB activation by a glucan ligand involves down regulation of 1KKβ kinase activity and altered phosphorylation and degradation of IκBα. Shock 13:446.
11. Williams, D. L., T. Ha, C. Li, J. H. Kalbfleisch, J. Schweitzer, W. Vogt, and I. W. Browder. 2003. Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit. Care Med. 31:1808.
12. Williams, D. L., R. B. McNamee, E. L. Jones, H. A. Pretus, H. E. Ensley, I. W. Browder, and N. R. Di Luzio, 1991. A method for the solubilization of a (1-3)-β-D-glucan isolated from Saccharomyces cerevisiae. Carbohydr. Res. 219:203.
13. Ensley, H. E., B. Tobias, H. A. Pretus, R. B. McNamee, E. L. Jones, I. W. Browder, and D. L. Williams. 1994. NMR spectral analysis of a water-insoluble (1-3)-β-D-glucan isolated from Saccharomyces cerevisiae. Carbohydr. Res. 258:307.
14. Mueller, A., H. Pretus, R. McNamee, E. Jones, I. Browder, and D. Williams. 1995. Comparison of the carbohydrate biological response modifiers Krestin, schizophyllan and glucan phosphate by aqueous size exclusion chromatography with in-line argon-ion multi-angle laser light scattering photometry and differential viscometry detectors. J. Chromatogr. 666:283.
15. Mueller, A., W. Mayberry, R. Acuff, S. Thedford, W. Browder, and D. Williams. 1994. Lipid content of macroparticulate (1→3)-β-D-glucan isolated from Saccharomyces cerevisiae. Microbios 79:253.
16. Lowman, D., H. Ensley, and D. Williams. 1998. Identification of phosphate substitution sites by NMR spectroscopy in a water-soluble phosphorylated (1→3)-β-D-glucan. Carbohyd. Res. 306:559.
17. Kambayashi, J., M. Yokota, M. Sakon, E. Shiba, T. Kawasaki, T. Mori, M. Tsuchiya, H. Oishi, and S. Matsuura. 1991. A novel endotoxin-specific assay by turbidimetry with Limulus ameobocyte lysate containing β-glucan. J. Biochem. Biophys. I Methods 22:93.
18. Miyazaki, T., S. Kohno, K. Mitsutake, S. Maesaki, K. Tanaka, and K. Hara. 1995. (1→3)-β-D-glucan in culture fluid of fungi activates factor G, a limulus coagulation factor. J. Clin. Lab. Anal. 9:334.
19. Baker, C. C., I. H. Chaudry, H. O. Gaines, and A. E. Baue. 1983. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94:331.
20. Yang, S., C. S. Chung, A. Ayala, I. H. Chaudry, and P. Wang. 2002. Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse. Shock 17:55.
21. Li, C., R. L. Kao, T. Ha, J. Kelley, I. W. Browder, and D. L. Williams. 2001. Early activation of 1KKβ during in vivo myocardial ischemia. Am. J. Physiol. 280:H1264.
22. Stein, R. C., and M. D. Waterfield. 2000. PI3-kinase inhibition: a target for drug development? Mol. Med. Today 6:347.
23. Stein, R. C. 2001. Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment. Endocrine-Related Cancer 8:237.
24. Shigematsu, K., H. Koyama, N. E. Olson, A. Cho, and M. A. Reidy. 2000. Phosphatidylinositol 3-kinase signaling is important for smooth muscle cell replication after arterial injury. Arterioscler. Thromb. Vasc. Biol. 20:2373.
25. Fukao, T., T. Yamada, M. Tanabe, Y. Terauchi, T. Ota, T. Takayama, T. Asano, T. Takeuchi, T. Kadowaki, J. Hata, et al. 2002. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K deficient mice. Nat. Immunol. 3:295.
26. Adi, S., N. Y. Wu, and S. M. Rosenthal. 2001. Growth factor-stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and wortmannin. Endocrinology 142:498.
27. Yum, H. K., J. Arcaroli, J. Kupfner, R. Shenkar, J. M. Penninger, T. Sasaki, K. Y. Kant, J. S. Park, and E. Abraham. 2001. Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J. Immunol. 167:6601.
28. Williams, D. L., A. Mueller, and W. Browder. 1996. Glucan-based macrophage stimulators: a review of their anti-infective potential. Clin. Immunother. 5:392.
29. Liang, J., D. Melican, L. Cafro, G. Palace, L. Fisette, R. Armstrong, and M. L. Patchen. 1998. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int. J. Immunopharm. 20:595.
30. Williams, D. L. 1997. Overview of (1→3)-β-D-glucan immunobiology. Mediat. Inflamm. 6:247.
31. Adams, D. S., S. C. Pero, J. B. Petro, R. Nathans, W. M. Mackin, and E. Wakshull. 1997. PGG-Glucan activates NF-κB-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line. J. Leukocyte Biol. 62:865.
32. Battle, J., T. Ha, C. Li, V. Della Beffa, P. Rice, J. Kalbfleisch, W. Browder, and Williams D. 1998. Ligand binding to the (1→3)-β-D-glucan receptor stimulates NFκB activation, but not apoptosis in U937 cells. Biochem. Biophys. Res. Commun. 249:499.
33. Ui, M., T. Okada, K. Hazeki, and O. Hazeki. 1995. Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. TIBS 20:303.
34. Fukao, T., M. Tanabe, Y. Terauchi, T. Ota, S. Matsuda, T. Asano, T. Kadowak, T. Takeuchi, and S. Koyasu. 2002. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3:875.
35. Remick, D., P. Manohar, G. Bolgos, J. Rodriguez, L. Moldawer, and G. Wollenburg. 1995. Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4:89.
36. Soltys, J., and M. T. Quinn. 1999. Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with β-(1,6)-branched β-(1,3)-glucan. Infect. Immun. 67:244.
37. Okazaki, M., Y. Adachi, N. Ohno, and T. Yadomae. 1995. Structure-activity relationship of (1→3)-β-glucans in the induction of cytokine production from macrophages in vitro. Biol. Pharm. Bull. 18:1320.
38. Yang, S., Y. P. Lim, M. Zhou, P. Salvemini, H. Schwinn, D. Josic, D. J. Koo, I. H. Chaudry, and P. Wang. 2002. Administration of human inter-α-inhibitors maintains hemodynamic stability and improves survival during sepsis. Crit. Care Med. 30:617.
39. Oberholzer, C., A. Oberholzer, M. Clare-Salzler, and L. L. Moldawer. 2001. Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J. 15:879.
40. Yang, K.-Y., J. Arcaroli, J. Kupfner, T. M. Pitts, J. S. Park, D. Strasshiem, R.-P. Perng, and E. Abraham. 2003. Involvement of phosphatidylinositol 3-kinase γ in neutrophil apoptosis. Cell. Signalling 15:225.
41. Bone, R. C. 1996. Sir Isaac Newton, sepsis, S1RS, and CARS. Crit. Care Med. 24:1125.